Immune system process

Immune system process

• Activation of immune response
  • IKBKG: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
• Immune effector process
  • CD40LG: CD40 ligand
  • FOXP3: forkhead box P3
  • LYST: lysosomal trafficking regulator
  • MSH2: mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
  • NOD2: nucleotide-binding oligomerization domain containing 2
  • TGFB1: transforming growth factor, beta 1
• Immune response
• Immune system development
• Leukocyte activation
• Leukocyte homeostasis
  • FOXP3: forkhead box P3
  • SOD1: superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
• Leukocyte migration
  • EDNRB: endothelin receptor type B
  • LYST: lysosomal trafficking regulator
  • SAA1: serum amyloid A1
  • SBDS: Shwachman-Bodian-Diamond syndrome
• Negative regulation of immune system process
  • COL3A1: collagen, type III, alpha 1
  • FOXP3: forkhead box P3
• Positive regulation of immune system process
  • IKBKG: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
  • TGFB1: transforming growth factor, beta 1
  • TGFBR2: transforming growth factor, beta receptor II (70/80kDa)
• Regulation of immune system process
  • COL3A1: collagen, type III, alpha 1
  • FOXP3: forkhead box P3
  • IKBKG: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
  • SOD1: superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))
  • TGFB1: transforming growth factor, beta 1
  • TGFBR2: transforming growth factor, beta receptor II (70/80kDa)
• Somatic diversification of immune receptors
  • CD40LG: CD40 ligand
  • MSH2: mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
  • TGFB1: transforming growth factor, beta 1
• Tolerance induction
  • TGFBR2: transforming growth factor, beta receptor II (70/80kDa)

Source: Gene Ontology Consortium (September 2008).